Blog
RSS FeedPosted by Michael Wonder on 27 Oct 2023
PHARMAC boss apologises over stories of patients self-funding treatments
28 October 2023 - PHARMAC's chief executive has apologised for making unprofessional comments about a journalist and stories of cancer ...
Posted by Michael Wonder on 27 Oct 2023
Terminal cancer patient wants 'complete overhaul' of PHARMAC
27 October 2023 - Instead of spending time with her six-year-old daughter, terminal cancer patient Vickie Hudson-Craig is fighting PHARMAC ...
Posted by Michael Wonder on 27 Oct 2023
PHARMAC Board endorse action plan to enhance organisational culture
27 October 2023 - At PHARMAC’s regular monthly Board meeting held today, the Board endorsed the action plan proposed by the ...
Posted by Michael Wonder on 11 Oct 2023
Rare Disorders NZ appalled by attitude within PHARMAC; calls for Chair’s removal
11 October 2023 - Rare Disorders New Zealand is calling on the Minister of Health to remove Steve Maharey as ...
Posted by Michael Wonder on 11 Oct 2023
PHARMAC needs to work for patients, not itself
10 October 2023 - “The internal chaos and siege mentality at PHARMAC is exactly why the next Government needs to ...
Posted by Michael Wonder on 10 Oct 2023
Calls to sack PHARMAC boss after 'sick, sneering' remarks
8 October 2023 - A top cancer specialist says PHARMAC chief executive Sarah Fitt should step down over “offensive” emails, ...
Posted by Michael Wonder on 27 Sep 2023
ICER appoints Daniel Ollendorf as Chief Scientific Officer and Director of HTA Methods and Engagement
27 September 2023 - Academic leader in HTA to rejoin ICER in November 2023. ...
Posted by Michael Wonder on 28 Jun 2023
ICER announces leadership transition
28 June 2023 - Founder and President Steve Pearson to transition to advisor role at beginning of 2024; long-time EVP ...
Posted by Michael Wonder on 20 Apr 2023
PHARMAC announces new Deputy Medical Director Māori
19 April 2023 - PHARMAC has welcomed Dr Kiri Prentice (Ngāi Tūhoe and Ngāti Awa) to the newly established role ...
Posted by Michael Wonder on 14 Mar 2023
CEO’s appointment to HTA Review Reference Committee
15 March 2023 - CEO of Medicines Australia, Elizabeth de Somer, has been appointed as the medicines industry representative on ...
Posted by Michael Wonder on 24 Feb 2023
Member of Canada’s drug pricing regulator quits over ‘lack of support’ for medicine cost reforms
23 February 2023 - A member of the Patented Medicine Prices Review Board, Canada’s drug pricing regulator, has resigned over ...
Posted by Michael Wonder on 16 Feb 2023
Thomas Kaiser becomes the new head of IQWiG
16 February 2023 - The current head of the IQWiG department for drug assessment succeeds Jürgen Windeler, who is retiring after ...
Posted by Michael Wonder on 02 Feb 2023
Professor John Skerritt retirement
2 February 2023 - Today, Professor John Skerritt has announced his decision to retire from his position of Deputy Secretary ...
Posted by Michael Wonder on 03 Jul 2022
New name for Department
1 July 2022 - The Department of Health is now called the Australian Government Department of Health and Aged Care. ...
Posted by Michael Wonder on 05 Jun 2022
The FDA’s Pazdur on accelerated approval, single-arm studies and his own future
4 June 2022 - When cancer drugs granted accelerated approval in the U.S. later turn out not to benefit patients, the ...